Clinical Trial Update: A Study Comparing 4 Dose Regimens of PLA-695, Naproxen, and Placebo In Subjects With Osteoarthritis Of The Knee [Phase 2]

View source ↗

Summary

Phase 2 study comparing four dose regimens of PLA-695, naproxen, and placebo in osteoarthritis of the knee, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Naproxen (Naproxen)
• PLA-695

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Osteoarthritis | Phase 2 | Status: TERMINATED